Ireland
--:--IST
Latest
Recruiting Observational

Anterior Cruciate Ligament Study

NCT06194682 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2023-12-06
Last updated
2024-01-08

Condition(s) studied

ACL InjuryACLAnterior Cruciate Ligament Rupture

Investigational drug(s) / intervention(s)

Anterior cruciate ligament reconstruction

Anterior cruciate ligament reconstruction: Anterior cruciate ligament arthroscopic reconstruction

Study summary

This retrospective, prospective observational study aims to evaluate the epidemiology and rate of anterior cruciate ligament re- rupture after surgery in patients treated from January 2020 to December 2030 by recording both clinically and radiographically ligament reconstruction.

The primary outcome is the rate of rupture of the anterior cruciate ligament as measured by the Lachmann test in which a positive value for re-rupture is an anterior translation of the tibia greater than 10mm relative to the femur Secondary Objectives: Verify predisposing factors to anterior cruciate ligament injuries (so anatomical factors such as tibial slope, trochlear groove), demographic factors (age, sex, weight, sports played), and the rate of return to sports, quality of life via questionnaires, and arthrosis at the operated knee

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * \- Males and females- attained skeletal maturity * 18-65 inclusive * Patients operated on anterior cruciate ligament reconstruction surgery at the Hospital's Casco unit from 2010 to 2030 * Signature informed consent for patients who will be operated on in the prospective phase (from CE approval date to 2030) Exclusion Criteria: * failure to reach skeletal maturity * Concomitant ligamentous injuries (pcl, mcl, lcl) * Neuropsychiatric illness, developmental disorders * Pregnant women through self-declaration or breastfeeding * Minors

Primary outcome measure(s)

  • Rerupture rate — 10 years
    rate of rerupture rare evaluated with anterior tibial translation

Trial sites (1)

FacilityCityRegionStatus
IRCCS Istituto Ortopedico Galeazzi Milan Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06194682 on ClinicalTrials.gov ↗ ← All trials in Italy